We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
-7.31%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.64B
AUM Growth
-$239M
Cap. Flow
-$76.2M
Cap. Flow %
-4.65%
Top 10 Hldgs %
45.73%
Holding
139
New
1
Increased
10
Reduced
53
Closed
1

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.24M
2
CRNC icon
Cerence
CRNC
+$315K
3
ZIMV
ZimVie
ZIMV
+$250K
4
CALX icon
Calix
CALX
+$157K
5
KFY icon
Korn Ferry
KFY
+$119K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$11.3M
2
SCHW
Charles Schwab
SCHW
+$9.32M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.31M
4
SNPS icon
Synopsys
SNPS
+$6.55M
5
MSFT icon
Microsoft
MSFT
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 41.59%
2 Communication Services 15%
3 Healthcare 14.31%
4 Consumer Discretionary 14.29%
5 Financials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMW
26
DELISTED
VMware, Inc
VMW
$19.6M 1.2%
172,160
+56
+0% +$6.79K
NVS icon
27
Novartis
NVS
$297B
$18.3M 1.12%
209,020
-4,454
-2% -$386K
LH icon
28
Labcorp
LH
$24.7B
$18.3M 1.12%
80,728
-1,107
-1% -$260K
AKAM icon
29
Akamai
AKAM
$16.4B
$17.9M 1.09%
149,740
– –
CRM icon
30
Salesforce
CRM
$142B
$17.8M 1.09%
84,031
+153
+0.2% +$32.9K
ACN icon
31
Accenture
ACN
$94.3B
$16.2M 0.99%
47,902
– –
MCK icon
32
McKesson
MCK
$99.5B
$16M 0.98%
52,303
-4,063
-7% -$1.1M
PFE icon
33
Pfizer
PFE
$141B
$15.9M 0.97%
308,051
+23,906
+8% +$1.24M
ZBH icon
34
Zimmer Biomet
ZBH
$17.8B
$15.9M 0.97%
124,671
-4,798
-4% -$578K
NTAP icon
35
NetApp
NTAP
$33.3B
$14.7M 0.9%
176,785
– –
GPN icon
36
Global Payments
GPN
$23B
$13.9M 0.85%
101,692
– –
ILMN icon
37
Illumina
ILMN
$28.7B
$11.8M 0.72%
34,596
-2,099
-6% -$709K
STT icon
38
State Street
STT
$50.7B
$9.6M 0.59%
110,160
-3,317
-3% -$307K
ISRG icon
39
Intuitive Surgical
ISRG
$128B
$9.14M 0.56%
30,292
-4,678
-13% -$1.37M
CHKP icon
40
Check Point Software Technologies
CHKP
$13.6B
$9.01M 0.55%
65,143
– –
DOX icon
41
Amdocs
DOX
$5.64B
$8.99M 0.55%
109,403
-3,740
-3% -$293K
GNTX icon
42
Gentex
GNTX
$4.88B
$8.38M 0.51%
287,392
-49,324
-15% -$1.53M
MDT icon
43
Medtronic
MDT
$108B
$8.17M 0.5%
73,626
– –
AIZ icon
44
Assurant
AIZ
$13.7B
$7.79M 0.48%
42,868
-1,533
-3% -$251K
GILD icon
45
Gilead Sciences
GILD
$162B
$7.17M 0.44%
120,666
-11,612
-9% -$742K
PAYX icon
46
Paychex
PAYX
$41.1B
$7.1M 0.43%
52,024
-4,650
-8% -$571K
GSK icon
47
GSK
GSK
$104B
$6.77M 0.41%
124,300
– –
BNY
48
Bank of New York Mellon
BNY
$107B
$5.68M 0.35%
114,505
-7,734
-6% -$440K
MHO icon
49
M/I Homes
MHO
$3.81B
$5.68M 0.35%
128,037
-4,496
-3% -$229K
PYPL icon
50
PayPal
PYPL
$49.5B
$5.49M 0.34%
47,493
-965
-2% -$128K
1
2
3 4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Oak Associates held 139 positions worth $1.64B, down 13% from $1.88B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $76.2M in Q1 2022, closing 1 position and reducing 53 holdings. Its most notable exit was CyrusOne Inc Common Stock, an estimated $403K position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Oak Associates opened a new position in ZimVie worth $242K.

  • Oak Associates's largest Q1 2022 buy was ZimVie: 10,616 shares worth $242K.
  • Oak Associates added most to Pfizer in Q1 2022, an estimated $1.24M increase.
  • Oak Associates's biggest Q1 2022 reduction was KLA, cutting an estimated $11.3M.
  • Oak Associates fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $403K.
  • Oak Associates's ten largest holdings make up 46% of its $1.64B portfolio in Q1 2022.
  • Oak Associates opened 1 new position and closed 1 in Q1 2022.
  • Oak Associates's portfolio value fell 13% quarter-over-quarter to $1.64B.

Based on Oak Associates's 13F filing for Q1 2022, filed 12 May 2022.